G 404 (Atovaquone and proguanil hydrochloride 250 mg / 100 mg)

Pill imprint G 404 has been identified as Atovaquone and proguanil hydrochloride 250 mg / 100 mg.

Atovaquone/proguanil is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial combinations. Risk cannot be ruled out during pregnancy. Atovaquone/proguanil 250 mg / 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G 404

Atovaquone and proguanil hydrochloride 250 mg / 100 mg G 404
Atovaquone and proguanil hydrochloride
Imprint:
G
404
Strength:
250 mg / 100 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimalarial combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc., USA
National Drug Code (NDC):
68462-0404
Inactive Ingredients:
microcrystalline cellulose
low substituted hydroxypropyl cellulose
poloxamer 188
povidone k30
silicon dioxide
magnesium stearate
polyethylene glycol 400
polyethylene glycol 8000
titanium dioxide
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)